PROCEPT BioRobotics Corporation (PRCT) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts PRCT Hot Sheet
Join SI Premium – FREE
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q2 EPS of ($0.35), $0.06 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $79.2 million versus the consensus estimate of $76.12 million.
For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Alcoa (AA) to Equalweight
- Atoss Software (AOF:GR) PT Lowered to EUR135 at Berenberg
- Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
